Trosovavilp alfa Biosimilar – Research Grade from ProteoGenix; catalogue PX-TA2518; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The latest biotech product designed to revolutionize the field of biopharmaceutical research. This biosimilar offers a cost-effective alternative to the original Trosovavilp alfa, while maintaining the same high-quality and efficacy.
At its core, Trosovavilp alfa Biosimilar – Research Grade is a recombinant protein that mimics the biological function of Trosovavilp alfa. It works by binding to specific receptors on cells, triggering a cascade of events that ultimately leads to the activation of the immune system. This makes it a powerful tool for studying the immune response and developing new therapies for a wide range of diseases.
One of the main applications of Trosovavilp alfa Biosimilar – Research Grade is in the field of immunology research. Its ability to activate the immune system makes it an ideal candidate for studying autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Additionally, it can be used to investigate the role of the immune system in cancer and infectious diseases.
But that’s not all – Trosovavilp alfa Biosimilar – Research Grade also has great potential in the development of new therapeutics. By understanding how this biosimilar activates the immune system, researchers can identify new therapeutic targets and develop more effective treatments for various diseases.
In terms of experimental use cases, Trosovavilp alfa Biosimilar – Research Grade has been successfully used in pre-clinical studies to assess its safety and efficacy. Its consistent and reliable performance has made it a popular choice among researchers, and its cost-effectiveness makes it accessible to a wider range of laboratories.
In conclusion, Trosovavilp alfa Biosimilar – Research Grade is a game-changing biotech product that offers a cost-effective solution for studying the immune response and developing new therapeutics. With its powerful biological function, diverse applications, and successful experimental use cases, it is a valuable addition to any biopharmaceutical research toolkit. So why wait? Try Trosovavilp alfa Biosimilar – Research Grade today and take your research to the next level.
ProteoGenix catalogue number PX-TA2518. For research use only.
Target: Trosovavilp alfa Biosimilar – Research Grade; Host: Mammalian cells; Clonality: Monoclonal Antibody; Expression system: Mammalian; Purity: >95% as determined by SDS-PAGE; Buffer: 0.01 M PBS pH 7.4.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
